VMP 41764711000001106

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Infliximab 100mg powder for solution for infusion vials
BNF code 1001030T0AAAAAA
Virtual Therapeutic Moiety Infliximab
Date identifier became valid 9 May 2023
Previous product identifier 400687000
Basis of preferred name rINN - Recommended International Non-proprietary
Date of name applicability 14 Jan 2009
Previous name Infliximab 100mg powder for solution for injection vials
Basis of previous name rINN - Recommended International Non-proprietary
Reason for name change Other
Prescribing status Caution - AMP level prescribing advised
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units vial
Unit dose unit of measure vial
Virtual Product Ingredient
Ingredient Infliximab
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 100.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route solutioninfusion.intravenous
Dose Form
Formulation Powder for solution for infusion
Drug Route
Route Intravenous
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Flixabi 100mg powder for concentrate for solution for infusion vials (Biogen Idec Ltd)
Inflectra 100mg powder for concentrate for solution for infusion vials (Pfizer Ltd)
Remicade 100mg powder for concentrate for solution for infusion vials (Janssen-Cilag Ltd)
Remsima 100mg powder for concentrate for solution for infusion vials (Celltrion Healthcare UK Ltd)
Zessly 100mg powder for concentrate for solution for infusion vials (Sandoz Ltd)
Virtual Medicinal Product Packs
Infliximab 100mg powder for solution for infusion vials 1 vial

dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.

Feedback